TC BioPharm secures European patent for cancer treatment [Yahoo! Finance]
TC BioPharm (Holdings) plc - American Depositary Shares (TCBP)
Company Research
Source: Yahoo! Finance
This marks a significant milestone for the company as it aligns with TCBP's commercial strategy in Europe. TC BioPharm CEO Bryan Kobel stated: “We are pleased to further expand our patent portfolio at TCBP with this European patent for modified gamma delta t-cells. “TCBP continues to focus on our immediate applications for TCB008 while developing future high-value gamma delta assets for other indications such as solid tumours. “We believe gamma deltas can be a high-impact therapeutic when modified with the potential to outpace current CAR [chimeric antigen receptor] and modified t-cells in safety and efficacy, patent protecting these approaches gives us a competitive moat and further value in a potential acquisition scenario.” In a related financial update, TCBP successfully closed an upsized public offering. The offering included six million shares of American Depository Shares (ADS) and Series H warrants to purchase an equivalent number of ADS. The combined public offer
Show less
Read more
Impact Snapshot
Event Time:
TCBP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TCBP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TCBP alerts
High impacting TC BioPharm (Holdings) plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
TCBP
News
- TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® GrantPR Newswire
- TCBP Provides Shareholder Update and Highlights Recent Milestone AchievementsPR Newswire
- TCBP Responds to False Social Media Claim [Yahoo! Finance]Yahoo! Finance
- TCBP Responds to False Social Media ClaimPR Newswire
- TCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox TherapeuticPR Newswire
TCBP
Sec Filings
- 11/14/24 - Form SC
- 10/11/24 - Form 6-K
- 8/30/24 - Form 6-K
- TCBP's page on the SEC website